IMMX
IMMX
US45258H1068
Immix Biopharma, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
29.956.415 22.674.680
32.1%
Operating Income -29.956.415 -22.674.680
32.1%
Pretax Income -29.400.889 -21.657.326
35.8%
Net Income Common Stockholders -29.438.613 -21.613.376
36.2%
-- --
--
-- --
--
ende